Lifecore Biomedical, Inc. (LFCR)
NASDAQ · Healthcare
Lifecore Biomedical, Inc. EPS 2010–2025
Lifecore Biomedical, Inc. annual/quarterly eps history and growth rate from 2010 to 2026. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- Lifecore Biomedical, Inc. eps for the quarter ending March 31, 2026 was $0.43, a 407.14% decrease year-over-year.
- Lifecore Biomedical, Inc. annual eps for 2025 was $1.27, a 484.85% decrease from 2024.
- Lifecore Biomedical, Inc. annual eps for 2024 was $0.33, a 109.94% decrease from 2023.
- Lifecore Biomedical, Inc. annual eps for 2023 was $3.32, a 16.37% decrease from 2022.
- Lifecore Biomedical, Inc. annual eps for 2022 was $3.97.
EPS
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Lifecore Biomedical, Inc. EPS — FAQ
Lifecore Biomedical, Inc. (LFCR) eps over the last 16 years — annual and quarterly figures with year-over-year growth and charts.
What is Lifecore Biomedical, Inc.'s eps?
Lifecore Biomedical, Inc. (LFCR) reported eps of $-1.27 for fiscal 2025.
Where can I see LFCR's eps history?
The chart and table above show Lifecore Biomedical, Inc.'s eps by year and by quarter, including the growth rate.